The serum concentration of S100A4 in the patients in Hurley stage II was significantly elevated compared to that of the controls and the individuals with HS in Hurley stage I (p = 0.005 and p = 0.012, respectively) (Figure 1b). This evidence concerns the gene S100A4 and histiocytic sarcoma.